Related Experiment Videos
Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its
1Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada M3N 3M5.
Abstract:
Altered responsiveness to extracellular signals and cell cycle dysregulation are hallmarks of cancer. The cell cycle is governed by cyclin-dependent kinases (cdks) that integrate mitogenic and growth inhibitory signals. Transforming growth factor (TGF)-beta mediates G1 cell cycle arrest by inducing or activating cdk inhibitors, and by inhibiting factors required for cdk activation. Mechanisms that lead to cell cycle arrest by TGF-beta are reviewed. Loss of growth inhibition by TGF-beta occurs early in breast cell transformation, and may contribute to breast cancer progression. Dysregulation of cell cycle effectors at many different levels may contribute to loss of G1 arrest by TGF-beta. Elucidation of these pathways in breast cancer may ultimately lead to novel and more effective treatments for this disease.
Insights
Transforming growth factor-beta (TGF-β) normally halts cell division. Loss of this growth inhibition is an early event in breast cancer, potentially driving disease progression.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cancer is characterized by altered cell signaling and cell cycle dysregulation.
- Cyclin-dependent kinases (cdks) regulate the cell cycle, integrating growth signals.
- Transforming growth factor-beta (TGF-β) is a key regulator of the G1 cell cycle arrest phase.
Purpose of the Study:
- To review the mechanisms by which TGF-β induces G1 cell cycle arrest.
- To explore the implications of TGF-β resistance in breast cancer development and progression.
- To identify potential therapeutic targets by understanding cell cycle regulation in breast cancer.
Main Methods:
- Literature review of studies on TGF-β signaling and cell cycle control.
- Analysis of molecular pathways involved in TGF-β-mediated G1 arrest.
- Examination of dysregulation of cell cycle effectors in breast cancer.
Main Results:
- TGF-β inhibits cell cycle progression by inducing cdk inhibitors and suppressing cdk activators.
- Loss of TGF-β-mediated growth inhibition is an early event in breast cell transformation.
- Multiple levels of dysregulation in cell cycle effectors can lead to resistance to TGF-β.
Conclusions:
- Understanding TGF-β pathways is crucial for comprehending breast cancer progression.
- Dysregulation of cell cycle control contributes to loss of tumor suppression.
- Elucidating these pathways may lead to novel therapeutic strategies for breast cancer.